SSI Diagnostica produces antisera for serotyping of Haemophilus influenzae.
Clinical relevance
Serotyping is used for surveillance in connection with H. influenzae type b vaccination (Hib) of children.
Background
H. influenzae antiserum from SSI Diagnostica is designed for in vitro diagnostic testing in clinical microbiological laboratories and reference laboratories.
The antiserum is polyclonal and produced by immunising rabbits with a well-defined reference strain.
Quality
SSI Diagnostica's antisera are high-quality, CE-marked and produced in accordance with DS/EN ISO 13485. The shelf life is 4 years from the date of production, and minimum 2 years from date of shipment.
Support
Serotyping: H. influenzae strains that cannot be serotyped using our antiserum can be sent to SSI Diagnostica, Herredsvejen 2, DK-3400 Hillerød, Denmark, for further investigation.
Technical: Enquiries concerning the use of our products should be directed to SSI Diagnostica, info@ssidiagnostica.com, tel.: +45 4829 9100.
Links to brochures, catalogues and package leaflets for the products can be found under the respective product descriptions.
